Atlas Venture Associates IX, LLC - Q2 2022 holdings

$44 Million is the total value of Atlas Venture Associates IX, LLC's 7 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .

 Value Shares↓ Weighting
SKLZ  SKILLZ INC$28,408,000
-58.7%
22,909,8590.0%64.55%
+2.1%
SURF  SURFACE ONCOLOGY INC$4,831,000
-44.2%
2,945,4530.0%10.98%
+37.8%
COGT SellCOGENT BIOSCIENCES INC$4,211,000
-38.7%
466,832
-49.1%
9.57%
+51.5%
SYBX  SYNLOGIC INC$3,049,000
-52.1%
2,651,9630.0%6.93%
+18.4%
SNAP  SNAP INCcl a$1,972,000
-63.5%
150,1600.0%4.48%
-9.8%
SPRO  SPERO THERAPEUTICS INC$1,019,000
-91.5%
1,376,9680.0%2.32%
-79.0%
NTLA  INTELLIA THERAPEUTICS INC$518,000
-28.7%
10,0000.0%1.18%
+75.9%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-11
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
INTELLIA THERAPEUTICS INC28Q3 2023100.0%
SNAP INC26Q3 202311.4%
SPERO THERAPEUTICS INC24Q3 202324.0%
SYNLOGIC INC24Q2 202335.6%
SURFACE ONCOLOGY INC21Q2 202333.3%
SKILLZ INC12Q3 202387.5%
UNUM THERAPEUTICS INC11Q3 202028.2%
COGENT BIOSCIENCES INC7Q2 20229.6%
CARBON BLACK INC6Q3 20197.8%
COHERUS BIOSCIENCES INC1Q3 202318.1%

View Atlas Venture Associates IX, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2023-11-13
13F-HR2023-08-08
13F-HR2023-05-08
13F-HR2023-01-31
13F-HR2022-11-10
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-01-27
13F-HR2021-11-04
13F-HR2021-08-11

View Atlas Venture Associates IX, LLC's complete filings history.

Compare quarters

Export Atlas Venture Associates IX, LLC's holdings